SCL and LMOI alter thymocyte differentiation: Inhibition of E2A-HEB function and pre-Tα chain expression

Nature Immunology

Volumn 1, Issue 2, 2000, Pages 138-144

  Herblot, Sabine ^a   Steff, Ann Muriel ^a,b   Hugo, Patrice ^a,b   Aplan, Peter D ^c   Hoang, Trang ^a,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD4 ANTIGEN; DNA BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; LMO1 PROTEIN, HUMAN; LMO1 PROTEIN, MOUSE; LMO2 PROTEIN, HUMAN; LMO2 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; METALLOPROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PRE T CELL RECEPTOR ALPHA; PRE-T CELL RECEPTOR ALPHA; TAL1 PROTEIN, HUMAN; TAL1 PROTEIN, MOUSE; TCF12 PROTEIN, HUMAN; TCF12 PROTEIN, MOUSE; TCF3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; THYMUS; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD4; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; MEMBRANE GLYCOPROTEINS; METALLOPROTEINS; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 0034252945     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/77819     Document Type: Article

References (50)

1. Bain, G. & Murre, C. The role of E-proteins. Semin. Immunol. 10, 143-153 (1998).
2. Robb, L. et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl Acad. Sci. USA 92, 7075-7079 (1995).
3. Porcher, C. et al. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86, 47-57 (1996).
4. Gering, M., Rodaway, A.R., Gottgens, B., Patient, R.K. & Green, A.R. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J. 17, 4029-4045 (1993).
5. Brady, G. et al. Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr. Biol. 5, 909-922 (1995).
6. Begley, C.G. & Green, A.R. The SCL gene: from case report to critical hematopoietic regulator. Blood 93, 2760-2770 (1999).
7. Wadman, I.A. et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 16, 3145-3157 (1997).
8. Grutz, G.G. et al. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J. 17, 4594-4605 (1998).
9. Ono, Y., Fukuhara, N. & Yoshie, O. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol. Cell Biol. 18, 6939-6950 (1998).
10. Krosl, G. et al. Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. J. Exp. Med. 188, 439-450 (1998).
11. Hsu, H.L. Wadman, I. & Baer, R. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc. Natl Acad. Sci. USA 91, 3181-3185 (1994).
12. Chervinsky, D.S. et al. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol. Cell Biol. 19, 5025-5035 (1999).
13. Larson, R.C. et al. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 15, 1021-1027 (1996).
14. Condorelli, G.L. et al. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res. 56, 5113-5119 (1996).
15. Kelliher, M.A., Seldin, D.C. & Leder, P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 15, 5160-5166 (1996).
16. Aplan, P.D. et al. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J. 16, 2408-2419 (1997).
17. Bain, G. et al. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell Biol. 17, 4782-4791 (1997).
18. Barndt, R., Dai, M.F. & Zhuang, Y. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during αβ thymopoiesis. J. Immunol. 163, 3331-3343 (1999).
19. Kim, D., Peng, X.C. & Sun, X.H. Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol. Cell Biol. 19, 8240-8253 (1999).
20. Blom, B. et al. Disruption of αβ but not of γδ T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors. EMBO J. 18, 2793-2802 (1999).
21. von Boehmer, H. et al. Pleiotropic changes controlled by the pre-T-cell receptor. Curr. Opin. Immunol. 11, 135-142 (1999).
22. Aplan, P.D. et al. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 250, 1426-1429 (1990).
23. Godfrey, D.I. & Zlotnik, A. Control points in early T-cell development. Immunol. Today 14, 547-553 (1993).
24. Mouthon, M.A. et al. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81, 647-455 (1993).
25. Kallianpur, A.R., Jordan, J.E. & Brandt, S.J. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83, 1200-1208 (1994).
26. Elefanty, A.G. et al. Characterization of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ "knock-in" strategy. Proc. Natl Acad. Sci. USA 95, 11897-11902 (1998).
27. Kenny, D.A., Jurata, L.W., Saga, Y. & Gill, G.N. Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. Proc. Natl Acad. Sci. USA 95, 11257-11262 (1998).
28. Anderson, G., Hare, K.J. & Jenkinson, E.J. Positive selection of thymocytes: the long and winding road. Immunol. Today 20, 463-468 (1999).
29. Wilson, R.B. et al. Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: implications for B-lymphoid-cell development. Mol. Cell Biol. 11, 6185-6191 (1991).
30. Reizis, B. & Leder, P. Expression of the mouse pre-T cell receptor α gene is controlled by an upstream region containing a transcriptional enhancer. J. Exp. Med. 189, 1669-1678 (1999).
31. Sawada, S. & Littman, D.R. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell Biol. 13, 5620-5628 (1993).
32. Winandy, S., Wu, L., Wang, J.H. & Georgopoulos, K. Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J. Exp. Med. 190, 1039-1048 (1999).
33. Henning, S.W. & Cantrell, D.A. p56lck signals for regulating thymocyte development can be distinguished by their dependency on Rho function. J. Exp. Med. 188, 931-939 (1998).
34. Bain, G., Romanow, W.J., Albers, K., Havran, W.L. & Murre, C. Positive and negative regulation of V(D)J recombination by the E2A proteins. J. Exp. Med. 189, 289-300 (1999).
35. Morrow, M.A., Mayer, E.W. Perez, C.A., Adlam, M. & Siu, G. Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36, 491-503 (1999).
36. Smith, K.S., Rhee, J.W., Naumovski, L. & Cleary, M.L. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice. Mol. Cell Biol. 19, 4443-4451 (1999).
37. Look, A.T. Oncogenic transcription factors in the human acute leukemias. Science 278, 1059-1064 (1997).
38. Wang, J. et al. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc. Natl Acad. Sci. USA 97, 3497-3502 (2000).
39. 1 progression by E2A and Id helix-loop-helix proteins. EMBO J. 13, 4291-4301 (1994).
40. Prabhu, S., Ignatova, A., Park, S.T. & Sun, X.H. Regulation of the expression of cyclin-dependent kinase inhibitor pit by E2A and Id proteins. Mol. Cell Biol. 17, 5888-5896 (1997).
41. McGuire, E.A., Rintoul, C.E., Sclar, G.M. & Korsmeyer, S.J. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma. Mol. Cell Biol. 12, 4186-4196 (1992).
42. Zhuang, Y., Cheng, P. & Weintraub, H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes. E2A, E2-2, and HEB. Mol. Cell Biol. 16, 2898-2905 (1996).
43. + subsets of thymocytes expressing intermediate or high levels of T cell receptor. Int Immunol. 3, 265-272 (1991).
44. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
45. Nordeen, S.K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6, 454-458 (1988).
46. Hernandez-Munain, C., Sleckman, B.P. & Krangel, M.S. A developmental switch from TCRδ enhancer to TCRa enhancer function during thymocyte maturation. Immunity 10, 723-733 (1999).
47. Aplan, P.D. et al. The SCL gene is formed from a transcriptionally complex locus. Mol. Cell Biol. 10, 6426-6435 (1990).
48. Dong, W.F. et al. Molecular characterization of a chromosome translocation breakpoint t(11;14)(p13;q11) from the cell line KOPT-K1. Leukemia 9, 1812-1817 (1995).
49. Nelson, C., Shen, L.P., Meister, A., Fodor, E. & Rutter, W.J. Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev. 4, 1035-1043 (1990).
50. Hawley, R.G., Lieu, F.H., Fong, A.Z. & Hawley, T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1, 136-138 (1994).